Demographic-Based Personalized Left Ventricular Hypertrophy Thresholds for Hypertrophic Cardiomyopathy Diagnosis
Hunain Shiwani(Barts Health NHS Trust), James Moon(Virginia Mason Medical Center), Camilla Torlasco(IRCCS Istituto Auxologico Italiano), Warren J. Manning(Beth Israel Deaconess Medical Center), Harold Litt(University of Pennsylvania), Constantin‐Cristian Topriceanu(Barts Health NHS Trust), Peter Kellman(National Institutes of Health), Clara Badia-Molins(Universitat Autònoma de Barcelona), Lia Crotti(IRCCS Istituto Auxologico Italiano), Betty Raman(John Radcliffe Hospital), Luís R. Lopes(Barts Health NHS Trust), Christopher M. Kramer(American College of Cardiology), João B. Augusto(Hospital Prof. Dr. Fernando Fonseca), Benjamin Dowsing(Barts Health NHS Trust), Anjali Owens(University of Pennsylvania), Walter R. Witschey(University of Pennsylvania), Saidi Mohiddin(St Bartholomew's Hospital), Rebecca Hughes(Barts Health NHS Trust), Gabriella Captur(The Royal Free Hospital), Raffaello Ditaranto(Barts Health NHS Trust), George Joy(St Bartholomew's Hospital), Victor A. Ferrari, Alun D. Hughes(University of Aberdeen), Rhodri Davies(Barts Health NHS Trust), Jessica Artico(University of Trieste), Elena Biagini, José F. Rodríguez‐Palomares, Raymond Y. Kwong(Brigham and Women's Hospital), Mario Cortina‐Borja(Great Ormond Street Hospital), Inês Miranda(Hospital Prof. Dr. Fernando Fonseca), Carolyn Y. Ho(Brigham and Women's Hospital), Michael L. Chuang(Dana (United States))
Cited by 40
Related Papers
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement
|Journal of Cardiovascular Magnetic Resonance|2013|1.1k
Criteria for Evaluation of Novel Markers of Cardiovascular Risk
|Circulation|2009|1.1k